Oscar S. Murillo
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Management of Infected Wounds: A Wound Healing Foundation Consensus Statement.
Journal: Advances in wound care
Published: June 16, 2026
Delafloxacin: what does a new fluoroquinolone offer?
Journal: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
Published: March 11, 2026
Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infections.
Journal: Antimicrobial agents and chemotherapy
Published: October 17, 2025
Exploring the Microbiome of Diabetic Foot Ulcers: A Focus on Cases with a Clinical Worse Outcome.
Journal: Antibiotics (Basel, Switzerland)
Published: May 30, 2025
Measurement of Total and Free Cefiderocol Concentrations in Human Plasma by UHPLC-MS/MS: Application to Patients With Difficult-To-Treat Gram-Negative Bacterial Infections.
Journal: Journal of separation science
Published: May 26, 2025
Exploring the subcutaneous route for dalbavancin administration in a long-term suppressive therapy of orthopaedic device-related infection.
Journal: International journal of antimicrobial agents
Published: January 02, 2025
Challenges and strategies in the treatment of periprosthetic joint infection caused by multidrug-resistant Gram-negative bacteria: a narrative review.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: December 15, 2024
The increasing prevalence of Enterobacteriaceae as pathogens of diabetic foot osteomyelitis: A multicentre European cohort over two decades.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: October 07, 2024
Collateral susceptibility-guided alternation of ceftolozane/tazobactam with imipenem prevents resistance development in XDR Pseudomonas aeruginosa biofilms.
Journal: Biofilm
Published: June 06, 2024
Comparative Efficacy of Continuous Ceftazidime Infusion vs. Intermittent Bolus against In Vitro Ceftazidime-Susceptible and -Resistant Pseudomonas aeruginosa Biofilm.
Journal: Antibiotics (Basel, Switzerland)
Published: March 14, 2024
Appropriate Duration of Antimicrobial Treatment for Prosthetic Joint Infections: A Narrative Review.
Appropriate Duration of Antimicrobial Treatment for Prosthetic Joint Infections: A Narrative Review.
Journal: Antibiotics (Basel, Switzerland)
Published: February 29, 2024
Last Updated: 09/26/2026